Teva Pharmaceutical Industries reported $769M in Pre-Tax Profit for its third fiscal quarter of 2022.

Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
Pre Tax Profit Change
Amarin AMRN:US USD -3883000 60.92M
AstraZeneca AZN:LN USD 3.09B 52M
Biogen BIIB:US USD 821M 53.8M
Coherus Biosciences CHRS:US USD -86650000 36.5M
GlaxoSmithKline GSK:LN GBP 2.43B 602M
Henry Schein HSIC:US USD 205M 9M
Horizon Pharma HZNP:US USD 315.1M 27.58M
Novartis NOVN:VX USD 4.06B 72M
Patterson Companies PDCO:US USD 40.41M 50.46M
Pfizer PFE:US USD 10.67B 3.11B
Revance Therapeutics RVNC:US USD -83993000 22.56M
Sun Pharmaceuticals SUNP:IN INR 24.12B 1.28B
Supernus Pharmaceuticals SUPN:US USD -444000 11.77M
Takeda 4502:JP JPY 64.55B 90.92B
Teva Pharmaceutical Industries TEVA:US USD 769M 62M